Exelon
NDC Package 0078-0339-31

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Exelon is rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Marketed by Novartis Pharmaceuticals Corporation, this product is identified by NDC 0078-0339 and is authorized under FDA application NDA021025.

Identification & Billing

NDC Package Code
0078-0339-31
Package Description
120 mL in 1 BOTTLE
Product Code
0078-0339
11-Digit Billing Format
00078033931
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
120 ML

Clinical Specifications

Proprietary Name
Exelon
Dosage Form
-
Usage Information
Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain.

Regulatory & Marketing

Labeler Name
Novartis Pharmaceuticals Corporation
FDA Application #
NDA021025
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-30-2000
End Marketing Date
12-18-2015
Listing Expiration
12-18-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0078-0339-31 identifies a specific commercial package of 120 ml in 1 bottle of Exelon, labeled by Novartis Pharmaceuticals Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 120 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Novartis Pharmaceuticals Corporation on April 30, 2000. The current certification is valid through December 18, 2015.

What are the primary indications for this medication?

Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain.

How is this Novartis Pharmaceuticals Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00078033931. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 120 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0078-0339-31
11-Digit CMS (5-4-2)
00078-0339-31

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.